Scarpa Marco, Bertin Matteo, Ruffolo Cesare, Polese Lino, D'Amico Davide F, Angriman Imerio
Department of Surgery, Veneto Oncological Institute (IOV-IRCCS), Padova, Italy.
J Surg Oncol. 2008 Oct 1;98(5):384-92. doi: 10.1002/jso.21120.
The aim of this work was to assess the prevalence of symptoms of gastrointestinal stromal tumors (GISTs) and the diagnostic yield of clinical procedures for its diagnosis.
Medical databases were consulted between 1998 and 2006 for potentially relevant publications. All studies dealing with the clinical presentation of GIST and related diagnostic procedures were included. Two researchers worked independently on the study selection, quality assessment, data extraction, and analysis phases of the study.
Forty-six observational studies were included with a total of 4,534 patients. Gastrointestinal bleeding was the most common clinical presentation. Twenty studies provided adequate information on the diagnostic yield of various procedures. The pooled diagnostic yield of endoscopy + mucosal biopsy and of intestinal contrast radiography was 33.8% (0-100%) and 35.1% (11-100%), respectively, while that of EUS and that of EUS-FNA was 68.7% (40-100%) and 84.0% (73.8-100%), respectively. Abdominal CT scan and MRI had similar pooled diagnostic yields: 73.6% (34.8-100%), and 91.7% (75-100%), respectively.
Endoscopy + mucosal biopsy should be reserved to patients with gastrointestinal bleeding. EUS-FNA provides direct visualization of the neoplasm and adequate samples for molecular diagnosis. EUS, abdominal CT and MRI may be considered valid alternatives whenever EUS-FNA is unavailable or a cytological diagnosis is unnecessary.
本研究旨在评估胃肠道间质瘤(GIST)症状的患病率及其诊断的临床程序的诊断率。
检索1998年至2006年期间的医学数据库,查找潜在相关出版物。纳入所有涉及GIST临床表现及相关诊断程序的研究。两名研究人员独立负责研究的选择、质量评估、数据提取和分析阶段。
纳入46项观察性研究,共4534例患者。胃肠道出血是最常见的临床表现。20项研究提供了关于各种程序诊断率的充分信息。内镜检查+黏膜活检和肠道造影的综合诊断率分别为33.8%(0-100%)和35.1%(11-100%),而超声内镜(EUS)和超声内镜引导下细针穿刺活检(EUS-FNA)的诊断率分别为68.7%(40-100%)和84.0%(73.8-100%)。腹部CT扫描和MRI的综合诊断率相似:分别为73.6%(34.8-100%)和91.7%(75-100%)。
内镜检查+黏膜活检应仅用于有胃肠道出血症状的患者。EUS-FNA可直接观察肿瘤并获取足够的样本进行分子诊断。当无法进行EUS-FNA或不需要细胞学诊断时,EUS、腹部CT和MRI可被视为有效的替代方法。